SlideShare a Scribd company logo
1 of 2
APhA Academy of Student Pharmacists
Midyear Regional Meetings
P R O P O S E D R E S O L U T I O N F O R M
Region #: 4
Proposing APhA-ASP Chapter: Cedarville University School of Pharmacy
Proposed Resolution Title/Topic: Pharmacy Interns Transferring Controlled Substances
Proposed wording (desired action(s)):
APhA-ASP supports the ability of licensed pharmacy interns, under the supervision of a pharmacist, to transfer
Schedule III, IV, and V controlled substance prescriptions in and out of pharmacies for refill purposes.
Background Statement (list reasons for the action(s) / pros and cons / references or resources):
The Title 21 Code of Federal Regulations currently states that the transfer of Schedule III, IV, and V
controlled substances must be communicated directly between two licensed pharmacists. This process may be
completed on a one-time basis for controlled substance prescriptions. The federal regulations allow licensed
pharmacy interns, under the supervision of a pharmacist, to transfer non-controlled prescriptions in and out of
pharmacies for refill purposes.1
The transfer process is essentially the same for both non-controlled and
controlled prescriptions, with only a few minor differences, based on respective state regulations. According to
the Ohio Revised Code, in order for licensed pharmacy interns to transfer non-controlled substance prescriptions,
they must abide by the following rules: the intern is determined to be competent in transferring prescriptions by
the supervising pharmacist, documentation is completed with the full names of the transferring and receiving
pharmacist and/or intern, the pharmacist on duty assumes full responsibility for the prescription copy, and the
supervising pharmacist must be immediately available to answer questions and discuss the transferred
prescription with the intern. These safeguards are appropriate in order to provide proper accountability for the
intern, implement a verification system, and ensure protection of the patient. Depending upon the state, licensed
pharmacy interns are eligible to perform professional duties such as: receiving oral prescriptions, selling Schedule
V controlled substances, compound, counsel patients, and administering vaccinations, as well as transferring non-
controlled prescriptions.2
Given the responsibilities already afforded to licensed pharmacy interns, it seems that
the addition of transferring controlled substance prescriptions would be a feasible opportunity to expand upon
their roles within the profession of pharmacy.
1. United States. Dept. of Justice. Drug Enforcement Administration. “Transfer of Schedules III-V
Prescription Information.” 21 CFR 1306.25. 2010.
2. Ohio State Board of Pharmacy. Ohio Administrative Code. “Pharmacy Interns Professional Functions.”
4729-5-08. 2007.
Are there any adopted resolutions currently on the books related to this Proposed Resolution? Yes___ No
_X_
If yes, please provide the number and title of the adopted resolution(s) as well as your rationale for the
addition of this Proposed Resolution:
Author of Proposed Resolution: Josh Willoughby
Author Phone Number: (513) 295-1065
Please use only one form for each proposed resolution. Forms must be submitted by the Chapter via email to the APhA-ASP
Regional Delegate two (2) weeks prior to the start of the Midyear Regional Meeting.
Author Email Address: jwilloughby@cedarville.edu
Please use only one form for each proposed resolution. Forms must be submitted by the Chapter via email to the APhA-ASP
Regional Delegate two (2) weeks prior to the start of the Midyear Regional Meeting.

More Related Content

What's hot

Gerald Subar CV 2015c
Gerald Subar CV 2015cGerald Subar CV 2015c
Gerald Subar CV 2015cGerald Subar
 
iHT² Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...
 iHT²  Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea... iHT²  Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...
iHT² Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...Health IT Conference – iHT2
 
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...Amy Demske
 
Emag chempack region d exercise presentation may 2010
Emag chempack region d exercise presentation may 2010Emag chempack region d exercise presentation may 2010
Emag chempack region d exercise presentation may 2010Chatham EMA
 
Medicines Transparency Kyrgyzstan
Medicines Transparency KyrgyzstanMedicines Transparency Kyrgyzstan
Medicines Transparency KyrgyzstanMeTApresents
 
CMS Advance Directives
CMS Advance DirectivesCMS Advance Directives
CMS Advance Directivescourtemanche
 
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLSReconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLSKatalyst HLS
 
Whitley Smith Resume 2015
Whitley Smith Resume 2015Whitley Smith Resume 2015
Whitley Smith Resume 2015Whitley Smith
 
Get accurate laboratory results in the ehr with pathology transcription
Get accurate laboratory results in the ehr with pathology transcriptionGet accurate laboratory results in the ehr with pathology transcription
Get accurate laboratory results in the ehr with pathology transcriptionMedical Transcription Service Company
 
Preparing a drug registration for the US and the EU: Parallel or sequential a...
Preparing a drug registration for the US and the EU: Parallel or sequential a...Preparing a drug registration for the US and the EU: Parallel or sequential a...
Preparing a drug registration for the US and the EU: Parallel or sequential a...Voisin Consulting Life Sciences
 
Global Pharma Primer (Syllabus)
Global Pharma Primer (Syllabus)Global Pharma Primer (Syllabus)
Global Pharma Primer (Syllabus)Arete-Zoe, LLC
 
Stem Cell Clinic Injunction
Stem Cell Clinic InjunctionStem Cell Clinic Injunction
Stem Cell Clinic InjunctionEMMAIntl
 
National annual report
National annual reportNational annual report
National annual reportCACTUS_JP
 

What's hot (20)

Gerald Subar CV 2015c
Gerald Subar CV 2015cGerald Subar CV 2015c
Gerald Subar CV 2015c
 
Heidi Resume 2016 - amb tech
Heidi Resume 2016 - amb techHeidi Resume 2016 - amb tech
Heidi Resume 2016 - amb tech
 
iHT² Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...
 iHT²  Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea... iHT²  Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...
iHT² Health IT Summit Denver - Laura McCrary,Executive Director, Kansas Hea...
 
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
 
Emag chempack region d exercise presentation may 2010
Emag chempack region d exercise presentation may 2010Emag chempack region d exercise presentation may 2010
Emag chempack region d exercise presentation may 2010
 
Medicines Transparency Kyrgyzstan
Medicines Transparency KyrgyzstanMedicines Transparency Kyrgyzstan
Medicines Transparency Kyrgyzstan
 
Career
CareerCareer
Career
 
CMS Advance Directives
CMS Advance DirectivesCMS Advance Directives
CMS Advance Directives
 
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLSReconciliation and Literature Review and Signal Detection_Katalyst HLS
Reconciliation and Literature Review and Signal Detection_Katalyst HLS
 
Towse future of CER in US
Towse future of CER in USTowse future of CER in US
Towse future of CER in US
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
 
Whitley Smith Resume 2015
Whitley Smith Resume 2015Whitley Smith Resume 2015
Whitley Smith Resume 2015
 
Resume 2016 W III
Resume 2016 W IIIResume 2016 W III
Resume 2016 W III
 
Get accurate laboratory results in the ehr with pathology transcription
Get accurate laboratory results in the ehr with pathology transcriptionGet accurate laboratory results in the ehr with pathology transcription
Get accurate laboratory results in the ehr with pathology transcription
 
Preparing a drug registration for the US and the EU: Parallel or sequential a...
Preparing a drug registration for the US and the EU: Parallel or sequential a...Preparing a drug registration for the US and the EU: Parallel or sequential a...
Preparing a drug registration for the US and the EU: Parallel or sequential a...
 
Drug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's PerspectiveDrug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's Perspective
 
GlobalOutreach
GlobalOutreachGlobalOutreach
GlobalOutreach
 
Global Pharma Primer (Syllabus)
Global Pharma Primer (Syllabus)Global Pharma Primer (Syllabus)
Global Pharma Primer (Syllabus)
 
Stem Cell Clinic Injunction
Stem Cell Clinic InjunctionStem Cell Clinic Injunction
Stem Cell Clinic Injunction
 
National annual report
National annual reportNational annual report
National annual report
 

Similar to 2016-2017 APhA-ASP MRM Resolution

ReferencesConclusionThe capacity to adapt is crucial.docx
ReferencesConclusionThe capacity to adapt is crucial.docxReferencesConclusionThe capacity to adapt is crucial.docx
ReferencesConclusionThe capacity to adapt is crucial.docxlorent8
 
14ab1t0030 hospital formulary
14ab1t0030   hospital formulary14ab1t0030   hospital formulary
14ab1t0030 hospital formularyRamesh Ganpisetti
 
04. Pharmacy _ Therapeutics Committee.pdf
04. Pharmacy _ Therapeutics Committee.pdf04. Pharmacy _ Therapeutics Committee.pdf
04. Pharmacy _ Therapeutics Committee.pdfmoyourtri
 
The Practice of Community of Pharmacy
The Practice of Community of PharmacyThe Practice of Community of Pharmacy
The Practice of Community of PharmacyPharmacy Universe
 
IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAMANIKANDAN V
 
Remote medication order processing
Remote medication order processingRemote medication order processing
Remote medication order processingSubodh Chataut
 
Med Rec And Terminology To Mcp 2008
Med Rec And Terminology To Mcp 2008Med Rec And Terminology To Mcp 2008
Med Rec And Terminology To Mcp 2008poikonen
 
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test Reports
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test ReportsCLIA Program and HIPAA Privacy Rule: Patients' Access to Test Reports
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test ReportsTrevor Thomas
 
Rx15 pharma tues_330_burns
Rx15 pharma tues_330_burnsRx15 pharma tues_330_burns
Rx15 pharma tues_330_burnsOPUNITE
 
1 front cover-preface and table of contents
1 front cover-preface and table of contents1 front cover-preface and table of contents
1 front cover-preface and table of contentsPharmacyTechnicianExam
 
HOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptxHOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptxAnilDhakal14
 
Regulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfRegulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfPriyansha Singh
 
Purchasing and inventory control
Purchasing and inventory controlPurchasing and inventory control
Purchasing and inventory controlMD Jahidul Islam
 

Similar to 2016-2017 APhA-ASP MRM Resolution (20)

ReferencesConclusionThe capacity to adapt is crucial.docx
ReferencesConclusionThe capacity to adapt is crucial.docxReferencesConclusionThe capacity to adapt is crucial.docx
ReferencesConclusionThe capacity to adapt is crucial.docx
 
Law update, march 2011
Law update, march 2011Law update, march 2011
Law update, march 2011
 
14ab1t0030 hospital formulary
14ab1t0030   hospital formulary14ab1t0030   hospital formulary
14ab1t0030 hospital formulary
 
Pharmacy practice
Pharmacy practicePharmacy practice
Pharmacy practice
 
04. Pharmacy _ Therapeutics Committee.pdf
04. Pharmacy _ Therapeutics Committee.pdf04. Pharmacy _ Therapeutics Committee.pdf
04. Pharmacy _ Therapeutics Committee.pdf
 
The Practice of Community of Pharmacy
The Practice of Community of PharmacyThe Practice of Community of Pharmacy
The Practice of Community of Pharmacy
 
IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDA
 
Remote medication order processing
Remote medication order processingRemote medication order processing
Remote medication order processing
 
Med Rec And Terminology To Mcp 2008
Med Rec And Terminology To Mcp 2008Med Rec And Terminology To Mcp 2008
Med Rec And Terminology To Mcp 2008
 
REBBA SAI SUSMITHA
REBBA SAI SUSMITHAREBBA SAI SUSMITHA
REBBA SAI SUSMITHA
 
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test Reports
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test ReportsCLIA Program and HIPAA Privacy Rule: Patients' Access to Test Reports
CLIA Program and HIPAA Privacy Rule: Patients' Access to Test Reports
 
Rx15 pharma tues_330_burns
Rx15 pharma tues_330_burnsRx15 pharma tues_330_burns
Rx15 pharma tues_330_burns
 
1 front cover-preface and table of contents
1 front cover-preface and table of contents1 front cover-preface and table of contents
1 front cover-preface and table of contents
 
IPR NDA and ANDA
IPR NDA and ANDAIPR NDA and ANDA
IPR NDA and ANDA
 
A. SANDHYA RANI
A. SANDHYA RANIA. SANDHYA RANI
A. SANDHYA RANI
 
Hospital &; community
Hospital &; community Hospital &; community
Hospital &; community
 
hospital formulary
hospital formularyhospital formulary
hospital formulary
 
HOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptxHOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptx
 
Regulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfRegulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdf
 
Purchasing and inventory control
Purchasing and inventory controlPurchasing and inventory control
Purchasing and inventory control
 

2016-2017 APhA-ASP MRM Resolution

  • 1. APhA Academy of Student Pharmacists Midyear Regional Meetings P R O P O S E D R E S O L U T I O N F O R M Region #: 4 Proposing APhA-ASP Chapter: Cedarville University School of Pharmacy Proposed Resolution Title/Topic: Pharmacy Interns Transferring Controlled Substances Proposed wording (desired action(s)): APhA-ASP supports the ability of licensed pharmacy interns, under the supervision of a pharmacist, to transfer Schedule III, IV, and V controlled substance prescriptions in and out of pharmacies for refill purposes. Background Statement (list reasons for the action(s) / pros and cons / references or resources): The Title 21 Code of Federal Regulations currently states that the transfer of Schedule III, IV, and V controlled substances must be communicated directly between two licensed pharmacists. This process may be completed on a one-time basis for controlled substance prescriptions. The federal regulations allow licensed pharmacy interns, under the supervision of a pharmacist, to transfer non-controlled prescriptions in and out of pharmacies for refill purposes.1 The transfer process is essentially the same for both non-controlled and controlled prescriptions, with only a few minor differences, based on respective state regulations. According to the Ohio Revised Code, in order for licensed pharmacy interns to transfer non-controlled substance prescriptions, they must abide by the following rules: the intern is determined to be competent in transferring prescriptions by the supervising pharmacist, documentation is completed with the full names of the transferring and receiving pharmacist and/or intern, the pharmacist on duty assumes full responsibility for the prescription copy, and the supervising pharmacist must be immediately available to answer questions and discuss the transferred prescription with the intern. These safeguards are appropriate in order to provide proper accountability for the intern, implement a verification system, and ensure protection of the patient. Depending upon the state, licensed pharmacy interns are eligible to perform professional duties such as: receiving oral prescriptions, selling Schedule V controlled substances, compound, counsel patients, and administering vaccinations, as well as transferring non- controlled prescriptions.2 Given the responsibilities already afforded to licensed pharmacy interns, it seems that the addition of transferring controlled substance prescriptions would be a feasible opportunity to expand upon their roles within the profession of pharmacy. 1. United States. Dept. of Justice. Drug Enforcement Administration. “Transfer of Schedules III-V Prescription Information.” 21 CFR 1306.25. 2010. 2. Ohio State Board of Pharmacy. Ohio Administrative Code. “Pharmacy Interns Professional Functions.” 4729-5-08. 2007. Are there any adopted resolutions currently on the books related to this Proposed Resolution? Yes___ No _X_ If yes, please provide the number and title of the adopted resolution(s) as well as your rationale for the addition of this Proposed Resolution: Author of Proposed Resolution: Josh Willoughby Author Phone Number: (513) 295-1065 Please use only one form for each proposed resolution. Forms must be submitted by the Chapter via email to the APhA-ASP Regional Delegate two (2) weeks prior to the start of the Midyear Regional Meeting.
  • 2. Author Email Address: jwilloughby@cedarville.edu Please use only one form for each proposed resolution. Forms must be submitted by the Chapter via email to the APhA-ASP Regional Delegate two (2) weeks prior to the start of the Midyear Regional Meeting.